Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Biosensors|March 27, 2024
Systematic Assessment of Human CCR7 Signalling Using NanoBRET Biosensors Points towards the Importance of the Cellular ContextNathan Vanalken, Katrijn Boon, Martyna Szpakowska, et al.
Cell Communication and Signaling : CCS|January 17, 2024
Systematic assessment of chemokine ligand bias at the human chemokine receptor CXCR2 indicates G protein bias over β-arrestin recruitment and receptor internalizationKatrijn Boon, Nathan Vanalken, Martyna Szpakowska, et al.
Pharmacological Reviews|October 7, 2024
International Union of Basic and Clinical Pharmacology. CXVIII. Update on the Nomenclature for Atypical Chemokine Receptors including ACKR5Andy Chevigné, Daniel F Legler, Antal Rot, et al.
Pharmacology & Therapeutics|October 8, 2021
Atypical opioid receptors: unconventional biology and therapeutic opportunitiesChristie B Palmer, Max Meyrath, Meritxell Canals, et al.
Frontiers in Immunology|April 19, 2014
Orchestration of an uncommon maturation cascade of the house dust mite protease allergen quartetMarie-Eve Dumez, Julie Herman, Vincenzo Campizi, et al.
Pharmacological Reviews|February 14, 2025
International Union of Basic and Clinical Pharmacology. CXVIII. Update on the nomenclature for atypical chemokine receptors, including ACKR5Andy Chevigné, Daniel F Legler, Antal Rot, et al.
International Journal of Molecular Sciences|June 28, 2017
Profiling the Extended Cleavage Specificity of the House Dust Mite Protease Allergens Der p 1, Der p 3 and Der p 6 for the Prediction of New Cell Surface Protein SubstratesAlain Jacquet, Vincenzo Campisi, Martyna Szpakowska, et al.
Biochemical Pharmacology|March 14, 2018
Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonistsMartyna Szpakowska, Max Meyrath, Nathan Reynders, et al.
Biochemical Pharmacology|September 1, 2012
Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptorsMartyna Szpakowska, Virginie Fievez, Karthik Arumugan, et al.
ACS Pharmacology & Translational Science|January 15, 2026
Deciphering Opioid Peptide Binding Modes at Atypical Chemokine Receptor 3Friederike Wunsch, Ester Cassano, Kristina Puls, et al.
Pageof 9